Matches in Wikidata for { <http://www.wikidata.org/entity/Q99589984> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q99589984 description "article scientifique publié en 2020" @default.
- Q99589984 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99589984 description "scientific article published on 18 September 2020" @default.
- Q99589984 description "wetenschappelijk artikel" @default.
- Q99589984 description "наукова стаття, опублікована 18 вересня 2020" @default.
- Q99589984 name "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 name "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 type Item @default.
- Q99589984 label "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 label "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 prefLabel "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 prefLabel "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 P1433 Q99589984-EAB791B8-9585-43DE-92ED-07E9F2B8DA4C @default.
- Q99589984 P1476 Q99589984-94E1E330-4F5D-487F-98E0-D01C5EA55F89 @default.
- Q99589984 P2093 Q99589984-08D3990D-ED27-4733-8ED6-413AA2F951A9 @default.
- Q99589984 P2093 Q99589984-09CE0AB0-BBCC-4492-A540-AA71539C2E05 @default.
- Q99589984 P2093 Q99589984-0A8A0102-6F5C-4BC9-9897-04DEC83026D5 @default.
- Q99589984 P2093 Q99589984-1F73CF89-A5DA-489A-8FB3-DE3282566822 @default.
- Q99589984 P2093 Q99589984-2B5DE434-FEFA-4DE2-AAD7-CCC56BDFDD24 @default.
- Q99589984 P2093 Q99589984-4626DCBE-9366-423F-A4E6-A38D7066A856 @default.
- Q99589984 P2093 Q99589984-727A6B28-56DD-41AC-ACB5-E73226CD43F2 @default.
- Q99589984 P2093 Q99589984-924E8BBF-3946-450E-A6C0-C81DEED45B9A @default.
- Q99589984 P2093 Q99589984-AAD30363-C3BD-426C-AB12-5852786BE3CE @default.
- Q99589984 P2093 Q99589984-B46527F7-8428-4616-92B4-CC70FBCEC527 @default.
- Q99589984 P2093 Q99589984-BA1B342A-47FD-49E5-A6D4-96F80EE55AE4 @default.
- Q99589984 P2093 Q99589984-DE727A95-49B7-41B0-B610-B7094172CA71 @default.
- Q99589984 P31 Q99589984-AE50BD2B-FFD9-4BF5-AC56-54481C450ACF @default.
- Q99589984 P356 Q99589984-944E19DD-BC6F-4140-8E41-E49E6E5BDE98 @default.
- Q99589984 P577 Q99589984-89AF8701-1F1C-4826-9B2E-63DB267FB23E @default.
- Q99589984 P698 Q99589984-8D42AE6C-1D89-4DA8-A4E4-362156982DAF @default.
- Q99589984 P921 Q99589984-BFD8AB0B-9BF2-4FD4-B6C6-3DE2B1558AC7 @default.
- Q99589984 P921 Q99589984-DBE53CB6-29A6-4BC2-A482-55F17BE149A1 @default.
- Q99589984 P356 J.JACI.2020.08.037 @default.
- Q99589984 P698 32956756 @default.
- Q99589984 P1433 Q7743550 @default.
- Q99589984 P1476 "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial" @default.
- Q99589984 P2093 "Amy D Klion" @default.
- Q99589984 P2093 "Andrew J Wardlaw" @default.
- Q99589984 P2093 "Eric S Bradford" @default.
- Q99589984 P2093 "Florence Roufosse" @default.
- Q99589984 P2093 "Gerald J Gleich" @default.
- Q99589984 P2093 "Jane H Bentley" @default.
- Q99589984 P2093 "Jean-Emmanuel Kahn" @default.
- Q99589984 P2093 "Jonathan Steinfeld" @default.
- Q99589984 P2093 "Marc E Rothenberg" @default.
- Q99589984 P2093 "Martyn J Gilson" @default.
- Q99589984 P2093 "Steven W Yancey" @default.
- Q99589984 P2093 "Suyong Yun Kirby" @default.
- Q99589984 P31 Q13442814 @default.
- Q99589984 P356 "10.1016/J.JACI.2020.08.037" @default.
- Q99589984 P577 "2020-09-18T00:00:00Z" @default.
- Q99589984 P698 "32956756" @default.
- Q99589984 P921 Q108853737 @default.
- Q99589984 P921 Q2551272 @default.